Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mansoura University
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Breast cancer patients who will receive paclitaxel post-anthracycline therapy.
2. Eastern Cooperative Oncology Group (ECOG) performance status from 0 to 2.
3. Adequate bone marrow function (white blood count ≥4,000/mm3, platelet count≥100,000/mm3), liver function (serum total bilirubin \<1.5 mg/dl), renal function (creatinine \< 1.5 mg/dl).
You may not be if
1. Patients with signs and symptoms of clinical neuropathy at baseline.
2. Patients with diabetes mellitus or alcoholic disease.
3. Patients receiving vitamin/ supplementation drugs that interfere with the study intervention.
Clareo Health | Efficacy of Cilostazol in Prevention of Peripheral Neuropathy
